In a report released today, Justin Smith from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF345.00. The company’s shares closed ...
Three athletes from Charlotte’s Corvian Community won NCHSAA 1A/2A indoor track championships Friday in Winston-Salem. ▪ ...
In a report released today, James Quigley from Goldman Sachs maintained a Sell rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF274.00. The company’s shares ...
1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
The Canadian Press on MSN3d
Multinational food and beverage firms push Canadian-made products amid tariff spatAmid a "buy Canadian" push inspired by trade tensions with the U.S., some multinational food and beverage companies are ...
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
If Canada were to become part of America, some changes would be in order. American history has seen the country grow in size and Betsy Ross’ flag grow in stars but Trump’s ideas ebb between ...
Roche Holding AG Akt-0.56% CHF240.64B ...
Roche Holding AG Akt 2.44% CHF240.64B ...
The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback